Literature DB >> 25104792

Pelvic nodal CTV from L4-L5 or aortic bifurcation? An audit of the patterns of regional failures in cervical cancer patients treated with pelvic radiotherapy.

Bhavana Rai1, Anshuma Bansal2, Firuza Patel2, Abhishek Gulia2, Rakesh Kapoor2, Suresh C Sharma2.   

Abstract

OBJECTIVE: To assess the patterns of recurrence in cervical cancer patients treated with pelvic nodal clinical target volume at L4-L5 junction instead of aortic bifurcation.
METHODS: Records of patients with locally advanced cervical cancer treated with chemo-radiation were reviewed. Patients treated with standard pelvic fields (superior border of the field at L4/L5 junction), without any radiological evidence of regional lymphadenopathy (<10 mm) were included in the study. The level of aortic bifurcation was retrospectively documented on computed tomography. Patterns of recurrences were correlated to the aortic bifurcation and the superior border of the radiation fields (L4/L5).
RESULTS: Aortic bifurcation was above the radiation fields (above L4/5) in 82 of 116 (70.7%) patients. Of the nine patients that recurred above the radiation field, 5 (55%) were above L4/5 failures, i.e. between aortic bifurcation and L4/5, and 4 (45%) had para-aortic failures. On retrospective analysis, 16 patients were found to have subcentimeter lymph nodes and higher nodal failures (7/16) were observed in patients with subcentimeter regional lymph nodes at diagnosis.
CONCLUSIONS: Superior border of nodal clinical target volume should ideally include the aortic bifurcation instead of L4-L5 inter space in patients with locally advanced cervical cancer. Radiotherapy fields need to be defined cautiously in patients with subcentimeter pelvic lymph nodes.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  L4–5; aortic bifurcation; cervical cancer; nodal CTV; subcentimeter nodes

Mesh:

Year:  2014        PMID: 25104792     DOI: 10.1093/jjco/hyu107

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  How well do elderly patients with cervical cancer tolerate definitive radiochemotherapy using RapidArc? Results from an institutional audit comparing elderly versus younger patients.

Authors:  Santam Chakraborty; M Geetha; Sampada Dessai; Vijay M Patil
Journal:  Ecancermedicalscience       Date:  2014-11-20

2.  Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06).

Authors:  Nalee Kim; Won Park
Journal:  J Gynecol Oncol       Date:  2021-05       Impact factor: 4.401

3.  Can We Apply National Cancer Grid of India Consensus Guidelines for the Management of Cervical Cancer in Low-Resource Settings?

Authors:  Linus Chuang
Journal:  J Glob Oncol       Date:  2018-07

4.  National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer.

Authors:  Supriya J Chopra; Ashwathy Mathew; Amita Maheshwari; Neerja Bhatla; Shalini Singh; Bhawana Rai; Shylasree T Surappa; Jaya Ghosh; Dayanand Sharma; Jaydip Bhaumik; Manash Biswas; Kedar Deodhar; Palak Popat; Sushil Giri; Umesh Mahantshetty; Hemant Tongaonkar; Ramesh Billimaga; Reena Engineer; Surbhi Grover; Abraham Pedicayil; Jyoti Bajpai; Bharat Rekhi; Aruna Alihari; Govind Babu; Rajkumar Thangrajan; Santosh Menon; Sneha Shah; Sidhanna Palled; Yogesh Kulkarni; Seema Gulia; Lavanya Naidu; Meenakshi Thakur; Venkatesh Rangrajan; Rajendra Kerkar; Sudeep Gupta; Shyam K Shrivastava
Journal:  J Glob Oncol       Date:  2018-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.